CollabRx Announces Receipt of NASDAQ Notice of Non-Compliance With Rule 5550(b)(1)
December 03, 2014 16:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Dec. 3, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company"), announced today that it received a letter from the NASDAQ OMX GROUP ("Nasdaq") stating...
CollabRx Announces Receipt of NASDAQ Notice of Bid Price Deficiency
November 24, 2014 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 24, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company"), announced today that it received a letter from the NASDAQ OMX GROUP ("Nasdaq") stating...
CollabRx Reports Second Quarter Fiscal Year 2015 Financial Results
November 13, 2014 16:00 ET
|
CollabRx, Inc.
SAN FRANCISCO, Nov. 13, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) announces financial results and business highlights for the second quarter of fiscal year 2015, which...
CollabRx and Cartagenia Partner in Interpretation Support and Reporting of Genetic Sequencing-Based Tests for Cancer
November 10, 2014 09:02 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) today announced a partnership with Cartagenia, Inc. to provide and promote to the clinical laboratory...
CollabRx and Collaborators at Leading Academic Centers Publish Clinical Decision Support Model for Precision Oncology
November 05, 2014 09:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (Nasdaq:CLRX), a leading provider of clinical decision support solutions in oncology, today announced the publication...
CollabRx Editor-in-Chief & CMO George D. Lundberg, MD Wins 2014 ASCP Ward Burdick Award for Distinguished Service to Pathology
October 17, 2014 09:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., Oct. 17, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (Nasdaq:CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology,...
CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data
September 11, 2014 09:04 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., Sept. 11, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology,...
CollabRx Reports First Quarter Fiscal Year 2015 Financial Results
August 14, 2014 16:00 ET
|
CollabRx, Inc.
SAN FRANCISCO, Aug. 14, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) announces financial results and business highlights for the first quarter of fiscal year 2015, which ended...
CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update
July 31, 2014 09:03 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a leading provider of expert systems that inform therapeutic decision-making in oncology, today...
CollabRx and OncoSolutions Cancer Center Partner To Provide Precision Oncology Services
June 26, 2014 09:03 ET
|
CollabRx, Inc.
SAN FRANCISCO, Calif., June 26, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a data analytics company and leading provider of expert systems that inform therapeutic...